Summary
Updated Aug 30, 2026
Dhiraj H. Malkani is CHIEF STRATEGY OFFICER of Kiniksa Pharmaceuticals International, plc (KNSA). 1 SEC Form 4 filing on record, dated 6 July 2026.
Trading Pattern
InsiderAlpha's records for Dhiraj H. Malkani go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Dhiraj H. Malkani files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sanj K. Patel - $39.43M of KNSA open-market activity in the last 12 months
- John F. Paolini - $8.00M of KNSA open-market activity in the last 12 months
- Eben Tessari - $7.24M of KNSA open-market activity in the last 12 months
- Mark Ragosa - $3.78M of KNSA open-market activity in the last 12 months
- Michael R. Megna - $2.66M of KNSA open-market activity in the last 12 months
- Barry D. Quart - $1.85M of KNSA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Dhiraj H. Malkani?
Dhiraj H. Malkani is a corporate insider, tracked as CHIEF STRATEGY OFFICER of Kiniksa Pharmaceuticals International, plc (KNSA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Dhiraj H. Malkani submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Dhiraj H. Malkani's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Dhiraj H. Malkani and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial